Gregory, A. P., C. A. Dendrou, K. E. Attfield, A. Haghikia, D. K. Xifara, F. Butter, G. Poschmann, G. Kaur, L. Lambert, O. A. Leach, S. Promel, D. Punwani, J. H. Felce, S. J. Davis, R. Gold, F. C. Nielsen, R. M. Siegel, M. Mann, J. I. Bell, G. McVean and L. Fugger: TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis. In: Nature 488, 7412, 508-511 (2012).
Vermeulen, M., H. C. Eberl, F. Matarese, H. Marks, S. Denissov, F. Butter, K. K. Lee, J. V. Olsen, A. A. Hyman, H. G. Stunnenberg and M. Mann: Quantitative Interaction Proteomics and Genome-wide Profiling of Epigenetic Histone Marks and Their Readers. In: Cell 142, 6, 967-980 (2010).
Butter, F., D. Kappei, F. Buchholz, M. Vermeulen and M. Mann: A domesticated transposon mediates the effects of a single-nucleotide polymorphism responsible for enhanced muscle growth. In: EMBO Reports 11, 4, 305-311 (2010).
Butter, F., M. Scheibe, M. Mörl and M. Mann: Unbiased RNA-protein interaction screen by quantitative proteomics. In: Proceedings of the National Academy of Sciences of the United States of America 106, 26, 10626-10631 (2009).
Mittler, G., F. Butter and M. Mann: A SILAC-based DNA protein interaction screen that identifies candidate binding proteins to functional DNA elements. In: Genome Research 19, 2, 284-293 (2009).
Olsen, J. V., F. Butter, N. Hubner, J. Cox, A. Hyman and M. Mann: SILAC based quantitative proteomics to determine specific protein-protein and protein-DNA interactions. In: FEBS Journal 275, Suppl. Suppl. 1, 29-29 (2008).
The Max Planck Society does not take any responsibility for the content of this export.